| Literature DB >> 31878172 |
Ya-Han Chen1,2, Dong-Sheng Guo2, Mei-Huan Lu2,3, Jian-Ying Yue1, Yan Liu4, Chun-Ming Shang4, De-Rong An2, Ming-Min Zhao1.
Abstract
The coumarin compound of osthole was extracted from Cnidium monnieri and identified by LC-MS and 1H- and 13C-NMR. Osthole was tested for anti-virus activity against tobacco mosaic virus (TMV) using the half-leaf method. The results showed that stronger antiviral activity on TMV infection appeared in Nicotiana glutinosa than that of eugenol and ningnanmycin, with inhibitory, protective, and curative effects of 72.57%, 70.26%, and 61.97%, respectively. Through observation of the TMV particles, we found that osthole could directly affect the viral particles. Correspondingly, the level of coat protein detected by Western blot was significantly reduced when the concentrations of osthole increased in tested plants compared to that of the control. These results suggest that osthole has anti-TMV activity and may be used as a biological reagent to control the plant virus in the half-leaf method.Entities:
Keywords: Cnidium monnieri; half-leaf method; inhibitory; osthole; tobacco mosaic virus
Mesh:
Substances:
Year: 2019 PMID: 31878172 PMCID: PMC6982833 DOI: 10.3390/molecules25010065
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The HPLC chromatogram of osthole.
Figure 2Samples and structure of the compound identified from osthole.
Figure 3The high-performance liquid chromatography/mass spectrometry (HPLC/MS) chromatogram of osthole. (A) The HPLC/MS of chromatogram of osthole. (B) The MS of chromatogram of osthole.
Figure 4Anti-tobacco mosaic virus (TMV) activities of osthole in N. glutinosa. The half-leaf was smeared with osthole extract mixed with TMV at the same volume, and the right half-leaf was smeared with 40 µL of TMV. (A) Osthole extract (5 mg/mL) and water. (B) Osthole extract (5 mg/mL) and TMV. (C) Ningnanmycin SL (8%; 1000-X dilution) and TMV.
The anti-viral activity of osthole against TMV.
| Drug | Inhibitory Effect (%) | Protective Effect (%) | Curative Effect (%) |
|---|---|---|---|
| Osthole | 72.57 ± 9.24 aA | 70.26 ± 10.49 aA | 61.97 ± 7.84 aA |
| Eugenol | 60.39 ± 5.48 aA | 56.04 ± 4.98 aA | 60.83 ± 4.49 bB |
| 8% Ningnanmycin SL | 64.11 ± 2.43 aA | 60.57 ± 7.24 aA | 55.45 ± 10.96 aA |
Values are presented as the mean ± SE. Different upper and lower letters in the same column indicate significant difference at p < 0.01 or p < 0.05 level by Duncan’s new multiple range test.
Figure 5Electron microscopic observation of TMV particles after treatment with osthole for 45 min. The concentration of the purified TMV was 0.60 mg/mL. The sample was observed under 49,000× magnifications using a Hitachi H-600 Electron Microscope. (A) Normal TMV particles. (B) TMV treated with osthole at 3 mg/mL for 45 min. (C) TMV treated with osthole at 5 mg/mL for 45 min.
Figure 6TMV coat protein (CP) accumulation detected by Western blot analysis.
The anti-viral activity of osthole against TMV at varying concentrations.
| Concentration (mg/mL) | Inhibitory Effect (%) |
|---|---|
| 1 | 34.46 ± 5.19 cC |
| 3 | 53.23 ± 3.13 bB |
| 5 | 72.57 ± 9.24 aA |
| 7 | 83.22 ± 3.68 aA |
Data in the table are mean ± SD. Different upper and lower letters in the same column indicate significant difference at p < 0.01 or p < 0.05 level by Duncan’s new multiple range test.